Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion type Assertion NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_head.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion description "[Based on the reviewed publications using representative cell lines and our preliminary findings on tumor tissue of patients with breast cancer, we infer that PKC-alpha levels may especially be increased in breast cancer patients with low or negative estrogen receptor (ER) levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_provenance.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion evidence source_evidence_literature NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_provenance.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion SIO_000772 15459489 NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_provenance.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion wasDerivedFrom befree-2016 NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_provenance.
- NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_assertion wasGeneratedBy ECO_0000203 NP462783.RAJ2jh52aAwGF9n9LjL-Mi-mZpDLcbvsYCBTK88sKsq5Q130_provenance.